The Centers for Disease Control and Prevention (CDC) has updated its recommendations regarding COVID-19 vaccinations for ...

NEW YORK — U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can cause ...

Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers ...

An agency panel recommended lowering the age for routine vaccination from 65 to 50, boosting the revenue outlook for multiple ...

Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 21. David Risinger ...

Pfizer's focus should remain on existing cost realignment plans and pipeline investments. Read why my investment thesis ...

which underpins Pfizer and BioNTech's COVID-19 vaccine. Tuesday's ruling relates to the London leg of Pfizer, BioNTech and CureVac's global legal battle, which also involves litigation in the ...

Although the pneumonia vaccine can’t prevent all cases, it can lower your chances of catching the disease. And if you’ve had the shot and you get pneumonia anyway, you will probably have a ...

This means adults have a choice in which COVID vaccine they receive: an mRNA vaccine by Moderna or Pfizer, or Novavax, a protein-based vaccine that targets the virus in a more "traditional" way.

The Public Health Agency of Canada (PHAC) says updated vaccines from Moderna and Pfizer-BioNTech are scheduled to arrive in provinces and territories by the end of next week. Pharmacies and public ...

Other companies, including Pfizer and Moderna, are continuing efforts to develop an mRNA bird flu vaccine, which is the same technology used in the companies' respective COVID-19 vaccines.

The effectiveness of this year's influenza vaccine was lower in South America than last season, the Centers for Disease Control and Prevention reported Thursday, which might be a clue to how much ...